The oversubscribed round was co-led by Forbion, FMC Ventures, and Corteva Inc.
"SOLASTA Bio has come a long way since we set out on this journey 3 years ago. Having established operations in the UK and US, we’ve now got an international team with outstanding competencies in technology and agribusiness and, importantly, we have developed our unique technology platform to address grower pain points. The results of our field trials have been hugely encouraging, demonstrating high efficacy of biopeptides against target insect pests, as effective or better than standard insecticides. With Series A now secured, it’s time for SOLASTA Bio to kick on to the next level and successfully hit our targets for commercialisation."
The funding will accelerate the commercial launch of the company's personal computing and automotive product ranges.
"Our force sensing and haptic feedback technologies not only make industry-leading haptic trackpads and force-enabled keyboards, but our control firmware and software does something that no other user interface product can: it makes the user interfaces intelligent. We use that intelligence to make PCs fundamentally easier, more engaging and more fun to use for every user type—from novices to professional content creators and gamers. This financial injection is a major endorsement to the success we’ve had in making better user experience platforms on Notebooks PCs and Peripherals and enables us to capitalize on our commercial wins and scale up for market share."
The investment round was led by Soulmates Ventures to support the company's global growth and U.S. presence.
"Our mission has always been to bridge the gap between technology and education, ensuring that every child, regardless of background, has access to quality STEM education"
